Director/PDMR Shareholding

Integrated Diagnostics Holdings PLC
23 June 2026
 

 

 

Integrated Diagnostic Holdings plc

23 June 2026

 

 

INTEGRATED DIAGNOSTIC HOLDINGS PLC

 

 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 

The following notification is intended to satisfy the Company's obligations under Article 19.3 of EU Regulation No 596/2014 (the Market Abuse Regulation).

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Legal Person:

 

Hena Holdings Ltd

 

2

Reason for the notification


a)

Position/status

PCA of Dr Hend El Sherbini, Chief Executive Officer

 

b)

Initial notification/Amendment

Initial Notification

3

Details of the issuer, UK emission allowance market participant, auction platform or auctioneer


a)

Name

Integrated Diagnostics Holdings plc

b)

LEI

2138007JN9NUWKKTS790

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

IDH Ordinary Share of $0.25 each

 

 

Identification Code: JE00BLKGSR75

b)

Nature of the transaction

Purchase of shares from Actis IDH Limited

c)

Price(s) and volume(s)

Price(s)                                                                                                 Volume(s)



Currency: USD

Price: 0.50

Volume: 126,000,000

Total: 63,000,000

d)

Aggregated information

 

Price: USD 0.50 per share

Volume: 126,000,000

Total: 63,000,000

e)

Date of the transaction

23 June 2026

f)

Place of the transaction

London Stock Exchange

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UK 100

Latest directors dealings